Cargando…
Multilocus genetic profiling to empower drug trials and predict brain atrophy()
Designers of clinical trials for Alzheimer's disease (AD) and mild cognitive impairment (MCI) are actively considering structural and functional neuroimaging, cerebrospinal fluid and genetic biomarkers to reduce the sample sizes needed to detect therapeutic effects. Genetic pre-selection, howev...
Autores principales: | Kohannim, Omid, Hua, Xue, Rajagopalan, Priya, Hibar, Derrek P., Jahanshad, Neda, Grill, Joshua D., Apostolova, Liana G., Toga, Arthur W., Jack, Clifford R., Weiner, Michael W., Thompson, Paul M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3777716/ https://www.ncbi.nlm.nih.gov/pubmed/24179834 http://dx.doi.org/10.1016/j.nicl.2013.05.007 |
Ejemplares similares
-
Multilocus Genetic Analysis of Brain Images
por: Hibar, Derrek P., et al.
Publicado: (2011) -
Discovery and Replication of Gene Influences on Brain Structure Using LASSO Regression
por: Kohannim, Omid, et al.
Publicado: (2012) -
Common folate gene variant, MTHFR C677T, is associated with brain structure in two independent cohorts of people with mild cognitive impairment()
por: Rajagopalan, Priya, et al.
Publicado: (2012) -
A single nucleotide polymorphism associated with reduced alcohol intake in the RASGRF2 gene predicts larger cortical volumes but faster longitudinal ventricular expansion in the elderly
por: Roussotte, Florence F., et al.
Publicado: (2013) -
ApoE4 effects on automated diagnostic classifiers for mild cognitive impairment and Alzheimer's disease
por: Apostolova, Liana G., et al.
Publicado: (2014)